K21 Coating for Miniscrew Stability and Peri-implant Inflammation
What You Need to Know Before You Apply
What is the purpose of this trial?
To determine if coating miniscrews with K21 would increase the success rate of orthodontic miniscrews by reducing adjacent tissue inflammation.
Do I need to stop my current medications to join the trial?
The trial does not specify if you need to stop taking your current medications, but you cannot participate if you are using certain bone-related medications that interfere with miniscrews.
What makes the K21 Cavity cleanser treatment unique for miniscrew stability and peri-implant inflammation?
Are You a Good Fit for This Trial?
This trial is for healthy individuals who need at least two miniscrews as part of their orthodontic treatment. Participants should have similar anatomical positions and mechanics indicated for each pair of miniscrews.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Placement of orthodontic miniscrews pretreated with K21 or ethanol for orthodontic therapy
Follow-up
Mobility and peri-implant inflammation assessed at follow-up appointments
What Are the Treatments Tested in This Trial?
Interventions
- Ethanol control
- K21 Cavity cleanser
Ethanol control is already approved in United States, European Union, Canada for the following indications:
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Colorado, Denver
Lead Sponsor